Neal D Bhatia MD

Dermatology•San Diego, CA

Physician

Join to View Full Profile

9025 Balboa AvenueSte 105San Diego, CA 92123
Phone+1 858-571-6800
Fax+1 858-571-6801

Education & Training

Medical College of Wisconsin Affiliated HospitalsResidency, Dermatology, 1995 - 1998
Medical College of Wisconsin Affiliated HospitalsResidency, Internal Medicine, 1993 - 1995
University of Wisconsin School of Medicine & Public HealthClass of 1993

Certifications & Licensure

CA State Medical License 1998 - 2026
WI State Medical License 1994 - 2025
AZ State Medical License 2003 - 2011
IA State Medical License 1998 - 2001
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Fellow (FAAD) American Academy of Dermatology
Fellow (FASDS) American Society for Dermatologic Surgery

Clinical Trials

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy Start of enrollment: 2014 Sep 01
Completed
Phase 2
Study of Glycopyrronium in Axillary Hyperhydrosis Start of enrollment: 2015 Jul 01
Completed
Phase 3
Long-term Safety Study of Glycopyrronium in Subjects With Primary Axillary Hyperhidrosis Start of enrollment: 2015 Aug 01
Completed
Phase 3
Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on Face Start of enrollment: 2016 Mar 01
Completed
Phase 2
Exploratory Study of Efficacy and Safety of Ingenol Mebutate 0.05% Gel for Common Warts on the Hands. Start of enrollment: 2016 Apr 27
Completed
Phase 1
Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp Start of enrollment: 2017 Mar 01
Withdrawn
Phase 3
A Study To Evaluate ASN002 In Subjects With Atopic Dermatitis Start of enrollment: 2017 Apr 12
Completed
Phase 1
A Clinical Trial to Evaluate the Safety, Tolerability, and Efficacy of Subjects With Plaque Psoriasis Start of enrollment: 2021 May 07
COMPLETED
PHASE2
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period Start of enrollment: 2023 Nov 06
ACTIVE_NOT_RECRUITING
PHASE3
Roles: Principal Investigator
Join now to see all

Publications & Presentations

PubMed

Correction: Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data ...
Neal Bhatia, Charles W Lynde, Luz Fonacier, Liyang Shao, Kwinten Bosman
Dermatology and Therapy. 2025-09-01
1 citations
Sofpironium topical gel, 12.45%, for the treatment of axillary hyperhidrosis: Pooled efficacy and safety results from 2 phase 3 randomized, controlled, double-blind st...
David Pariser, Dee Anna Glaser, James Del Rosso, Neal Bhatia, Deirdre Hooper
Journal of the American Academy of Dermatology. 2025-07-01
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.
Melinda J Gooderham, Javier Alonso-Llamazares, Jerry Bagel, Neal Bhatia, Michael Bukhalo
JAMA Dermatology. 2025-07-01

Lectures

Acne Boot Camp
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
Caribbean Dermatology Symposium, Inc. 8th Annual Coastal Dermatology Symposium
Caribbean Dermatology Symposium, Inc., Napa, California - 9/26/2012

Press Mentions

Soligenix Corporate Update Letter - Key Highlights and Upcoming MilestonesJuly 8th, 2025
Rosacea: Newer Approaches to Diagnosis, ManagementMarch 3rd, 2025
SNGX: Presentation Highlights HyBryte Potential in CTCL…February 24th, 2025
Join now to see all

Professional Memberships

American Academy of Dermatology - AAD
Fellow
American Society for Dermatologic Surgery - ASDS
Fellow